Nuclear matrix protein (NMP) levels in patients with acute pancreatitis

Journal of Medicine

Volumn 31, Issue 5-6, 2000, Pages 320-326

  Endo, Shigeatsu ^a   Inada, Katsuya ^a   Inoue, Yoshihiro ^a   Yamada, Yasuhiko ^a   Fujino, Yasuhisa ^a   Miura, Masanao ^b   Baba, Eiitsu ^b   Sato, Nobuhiro ^a   Wakabayashi, Go ^c   Katsuya, Hirotada ^d   Sato, Shigehiro ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Nuclear matrix protein; Pancreatitis

Indexed keywords

MATRIX PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ADULT; APOPTOSIS; ARTICLE; CELL NUCLEUS MATRIX; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MULTIPLE ORGAN FAILURE; SURVIVAL;

ACUTE DISEASE; ADULT; AGED; ANTIGENS, NUCLEAR; APOPTOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NUCLEAR PROTEINS; PANCREATITIS; STATISTICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 6644221334     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Marshall, J.C., Cook, D.J. and Christou, N.V. (1995).: Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit. Care Med. 23: 1638-52.
2. Miller, T.E., Beausang, L.A., Winchell, L.F. and Lidgard, G.P. (1992).: Detection of nuclear matrix protein in serum from cancer patients. Cancer 52: 422-427.
3. Miller, T.E., Beausang, L.A., Meneghini, M. and Lidgard, G. (1993).: Death-induced changes to the nuclear matrix: the use of antinuclear matrix antibodies to study agents of apoptosis. BioTechniques 15: 1042-1047.
4. Tanaka, M., Suda, T., Takahashi, T., et al.(1995).: Expression of the functional soluble form of human Fas ligand activated lymphocytes. EMBO J. 14: 1129-1135.
5. Yamada, Y., Endo, S., Kasai, T., Koike, S., Takakuwa, T., Inoue, Y., Niimi, M., Endo, Y., Wakabayashi, G. and Inada, K. (1998).: Nuclear matrix protein, tumor necrosis factor-(White vertical rectangle), and nitrite/nitrate levels in patients with multiple organ dysfunction syndrome. Res. Commun. Molecu. Pathol. Pharmacol. 100: 92-104.
6. Yamada, Y., Endo, S., Nakae, H., Kamei, Y., Taniguchi, S., Ishikura, H., Tanaka, T., Taki, K. and Inada, K. (1999).: Nuclear matrix protein levels in burn patients with multiple organ dysfunction syndrome. Burns 25: 705-708.